Skip to main content
Log in

Acute Gastroenteritis in Children

Role of Anti-Emetic Medication for Gastroenteritis-Related Vomiting

  • Review Article
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Acute gastroenteritis is associated with significant morbidity in developed countries and each year is the cause of death of several million children in developing countries. Acute gastroenteritis is usually self-limiting. Oral rehydration therapy (ORT) is effective and successful in the majority of patients. Vomiting is common at the outset of viral gastroenteritis and can limit the effectiveness of ORT. Treatment with newer anti-emetic medications has been reported to facilitate ORT and to minimize the risk of dehydration and the need for intravenous hydration and hospitalization.

The role of anti-emetic medications in the treatment of gastroenteritis-related vomiting is not clear. Some physicians agree with the use of anti-emetic medications because vomiting is unpleasant and distressing for the child and parents alike, and because vomiting can increase the likelihood of dehydration, electrolyte imbalance, and the need for intravenous hydration or hospitalization. Several surveys have shown that anti-emetic medications are commonly prescribed in the treatment of pediatric gastroenteritis and that adverse events are uncommon. Efficacy studies of the newer anti-emetic medications are now available and reveal that some are effective and help facilitate ORT. Other physicians disagree with the use of anti-emetic medications because acute gastroenteritis is a self-limiting condition, vomiting might help rid the body of toxic substances, there was previously a relative lack of published evidence of clinical benefit, and there are potential adverse events associated with the use of an anti-emetic medication.

Anti-emetic medications that are currently available include ondansetron, granisetron, tropisetron, dolasetron, ramosetron, promethazine, dimenhydrinate, metoclopramide, domperidone, droperidol, prochlorperazine, and trimethobenzamide. Randomized, placebo-controlled trials suggest that ondansetron is efficacious and superior to other anti-emetic medications in the treatment of gastroenteritis-related vomiting. A recent double-blind clinical trial showed that a single oral dose of ondansetron reduces gastroenteritis-related vomiting and facilitates ORT without significant adverse events. Ondansetron shows promise as a first-line anti-emetic, and judicious use of this agent might increase the success of ORT, minimize the need for intravenous therapy and hospitalization, and reduce healthcare costs. Ondansetron should be considered in situations where vomiting hinders ORT, but a larger randomized, placebo-controlled trial is necessary before the medication can be routinely recommended for the treatment of gastroenteritis-related vomiting in children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cubbedu LX, Trujllo LM, Talmaciu I, et al. Anti-emetic activity of odansetron in acute gastroenteritis. Aliment Pharmacol Ther 1997; 11: 185–91

    Article  Google Scholar 

  2. American Academy of Pediatrics, Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis. Practice parameter: the management of acute gastroenteritis in young children. Pediatrics 1996; 97: 424–35

    Google Scholar 

  3. Freedman SB, Adler M, Seshadri R, et al. Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med 2006; 354: 1698–705

    Article  PubMed  CAS  Google Scholar 

  4. Ramsook C, Sahagun-Curreon I, Kuzinetz CA, et al. A randomized clinical trial comparing oral ondansetron with placebo in children with vomiting from acute gastroenteritis. Ann Emerg Med 2002; 39: 397–403

    Article  PubMed  Google Scholar 

  5. Reeves JJ, Shannon MW, Fleisher GR. Ondansetron decreases vomiting associated with acute gastroenteritis: a randomized controlled trial. Pediatrics 2002; 109(4): e62

    Article  PubMed  Google Scholar 

  6. van Eygen M, Heck E, Dhondt F, et al. A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children. Postgrad Med J 1979; 55Suppl. 1: 36–9

    PubMed  Google Scholar 

  7. Dalby-Payne J, Elliott E. Gastroenteritis in children. Clin Evid 2004; 12: 443–54

    PubMed  Google Scholar 

  8. Leung AK, Kellner JD, Davies HD. Rotavirus gastroenteritis. Adv Ther 2005; 22: 476–87

    Article  PubMed  Google Scholar 

  9. Leung AK, Robson WL, Davies HD. Travelers’ diarrhea. Adv Ther 2006; 23: 519–27

    Article  PubMed  CAS  Google Scholar 

  10. Murray KF, Christie DL. Vomiting. Pediatr Rev 1998; 19: 337–41

    Article  PubMed  CAS  Google Scholar 

  11. Burkhart D. Management of acute gastroenteritis in children. Am Fam Physician 1999; 60: 2555–63

    PubMed  CAS  Google Scholar 

  12. Northrup RS, Flanigan TP. Gastroenteritis. Pediatr Rev 1994; 15: 461–71

    PubMed  CAS  Google Scholar 

  13. Glass R, Lew J, Gangarosa R, et al. Estimates of morbidity and mortality rates for diarrheal diseases in American children. J Pediatr 1991; 118: S27–33

    Article  PubMed  CAS  Google Scholar 

  14. Ho MS, Glass RI, Pinsky PF, et al. Diarrheal deaths in American children: are they preventable? JAMA 1988; 260: 3281–5

    Article  PubMed  CAS  Google Scholar 

  15. Kwon KT, Rudkin SE, Langdorf MI. Anti-emetic use in pediatric gastroenteritis: a national survey of emergency physicians, pediatricians, and pediatric emergency physicians. Clin Pediatr 2002; 41: 641–52

    Article  Google Scholar 

  16. King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003; 52(RR16): 1–16

    PubMed  Google Scholar 

  17. Santosham M. Oral rehydration therapy: reverse transfer of technology. Arch Pediatr Adolesc Med 2002; 156: 1177–9

    PubMed  Google Scholar 

  18. Jafri S, Pasricha PJ. Antinausea and anti-emetic medications. In: Hardman JG, Limbird LE, Gilman AG, editors. Goodman & Gilman’s the pharmacological basics of therapeutics. New York: McGraw-Hill, 2001: 1029–33

    Google Scholar 

  19. Keller VE. Management of nausea and vomiting in children. J Pediatr Nurs 1995; 10: 280–6

    Article  PubMed  CAS  Google Scholar 

  20. Freedman SB, Fuchs S. Anti-emetic therapy in pediatric emergency departments. Pediatr Emerg Care 2004; 20: 625–32

    Article  PubMed  Google Scholar 

  21. Gregory RE, Ettinger DS. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting: a comparison of their pharmacology and clinical efficacy. Drugs 1998; 55: 173–89

    Article  PubMed  CAS  Google Scholar 

  22. Olutoye O, Watcha MF. Management of postoperative vomiting in pediatric patients. Int Anesth Clin 2003; 41: 99–117

    Article  Google Scholar 

  23. Flake ZA, Scalley RD, Bailey AG. Practical selection of anti-emetic medication. Am Fam Physician 2004; 69: 1169–74

    PubMed  Google Scholar 

  24. Acker ME. Vomiting in children: a comprehensive review. Adv Nurse Pract 2002; 31: 51–68

    Google Scholar 

  25. Duggan C, Lasche J, McCarty M, et al. Oral rehydration solution for acute diarrhea prevents subsequent unscheduled follow-up visits. Pediatrics 1999; 104(3): e29

    Article  PubMed  CAS  Google Scholar 

  26. Leung AK, Darling P, Auclair C. Oral rehydration therapy: a review. J R Soc Health 1987; 107: 64–7

    Article  PubMed  CAS  Google Scholar 

  27. Issenman RM, Leung AK. Oral and intravenous rehydration of children. Can Fam Physician 1993; 39: 2129–36

    PubMed  CAS  Google Scholar 

  28. Nutrition and Gastroenterology Committee, Canadian Paediatric Society. Oral rehydration therapy and early refeeding in the management of childhood gastroenteritis. Paediatr Child Health 2006; 11: 527–31

    Google Scholar 

  29. Report of an ESPGAN Working Group. Recommendations for composition of oral rehydration solutions for children of Europe. J Pediatr Gastroenterol Nutr 1992; 14: 113–5

    Article  Google Scholar 

  30. Leung AK, Taylor PG, Geoffroy L, et al. Efficacy and safety of two oral solutions as maintenance therapy for acute diarrhea: a double-blind, randomized, multi-center trial. Clin Pediatr (Phila) 1988; 31: 631–5

    CAS  Google Scholar 

  31. Santosham M, Burns B, Nadkami V, et al. Oral rehydration therapy for acute diarrhea in ambulatory children in the United States: a double-blind comparison of four different solutions. Pediatrics 1985; 76: 159–66

    PubMed  CAS  Google Scholar 

  32. Tamer AM, Friedman LB, Maxwell SR, et al. Oral rehydration of infants in a large urban US medical center. J Pediatr 1985; 107: 14–9

    Article  PubMed  CAS  Google Scholar 

  33. Leung AK, Robson WL. Acute diarrhea in children: what to do and what not to do. Postgrad Med 1989; 86(8): 161–74

    PubMed  CAS  Google Scholar 

  34. Sentongo TA. The use of oral rehydration solutions in children and adults. Curr Gastroenterol Rep 2004; 6: 307–13

    Article  PubMed  Google Scholar 

  35. Ernst AA, Weiss SJ, Park S, et al. Prochlorperazine versus promethazine for uncomplicated nausea and vomiting in the emergency department: a randomized, double-blind clinical trial. Ann Emerg Med 2000; 36: 89–94

    Article  PubMed  CAS  Google Scholar 

  36. Li STT, DiGiuseppe DL, Christakis DA. Anti-emetic use for acute gastroenteritis in children. Arch Pediatr Adolesc Med 2003; 157: 475–9

    Article  PubMed  Google Scholar 

  37. Elliott EJ, Backhouse JA, Leach JW. Pre-admission management of acute gastroenteritis. J Paediatr Child Health 1996; 32: 18–21

    Article  PubMed  CAS  Google Scholar 

  38. O’Loughlin EV, Notaras E, McCullough C, et al. Home-based management of children hospitalized with acute gastroenteritis. J Paediatr Child Health 1995; 31: 189–91

    Article  PubMed  Google Scholar 

  39. Webb A, Starr M. Acute gastroenteritis in children. Aust Fam Physician 2005; 34: 227–31

    PubMed  Google Scholar 

  40. Christakis DA, Wright JA, Rivara F. Promethazine therapy for gastroenteritis: towards a better understanding of use, risks and benefits. Ambul Child Health 1998; 4: 181–7

    Google Scholar 

  41. Albano F, Bruzzese E, Spagnuolo M, et al. Antiemetics for children with gastroenteritis: off label but still on in clinical practice. J Pediatr Gastroenterol Nutr 2006; 43: 402–4

    Article  PubMed  Google Scholar 

  42. Alhashimi D, Alhashimi H, Fedorowicz Z. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst Rev 2006 Oct 18; (4): CD005506

    Google Scholar 

  43. Roila F, Del Favero A. Ondansetron clinical pharmacokinetics. Clin Pharmacokinet 1995; 29: 95–109

    Article  PubMed  CAS  Google Scholar 

  44. Culy CR, Bhana N, Plosker GL. Ondansetron: a review of its use as an anti-emetic in children. Pediatr Drugs 2001; 3: 441–79

    Article  CAS  Google Scholar 

  45. Scuderi PE. Pharmacology of anti-emetic medication. Int Anesth Clin 2003; 41: 41–66

    Article  Google Scholar 

  46. Carden PA, Mitchell SL, Waters KD, et al. Prevention of cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukemia. J Clin Oncol 1990; 8: 1531–5

    PubMed  CAS  Google Scholar 

  47. Cohen IJ, Zehavi N, Buchwald I, et al. Oral ondansetron: an effective ambulatory complement to intravenous ondansetron in the control of chemotherapy-induced nausea and vomiting in children. Pediatr Hematol Oncol 1995; 12: 67–72

    Article  PubMed  CAS  Google Scholar 

  48. Hewitt M, McQuade B, Stevens R. The efficacy and safety of ondansetron in the prophylaxis of cancer-chemotherapy induced nausea and vomiting in children. Clin Oncol R Coll Radiol 1993; 5: 11–4

    Article  PubMed  CAS  Google Scholar 

  49. Holdsworth MT, Raisch DW, Duncan MH, et al. Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia. Ann Pharmacother 1995; 29: 16–21

    PubMed  CAS  Google Scholar 

  50. Jurgens H, McQuade B. Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children. Oncology 1992; 49: 279–85

    Article  PubMed  CAS  Google Scholar 

  51. Kolecki P, Wachowiak J, Beshari SE. Ondansetron as an effective drug in prophylaxis of chemotherapy-induced emesis in children. Acta Hematol Pol 1993; 24: 115–22

    CAS  Google Scholar 

  52. Lippens RJ, Broeders GC. Ondansetron in radiation therapy of brain tumor in children. Pediatr Hematol Oncol 1996; 13: 247–52

    Article  PubMed  CAS  Google Scholar 

  53. Pinkerton CR, Williams D, Wootton C, et al. 5-HT3 antagonist ondansetron: an effective outpatient anti-emetic in cancer treatment. Arch Dis Child 1990; 65: 822–5

    Article  PubMed  CAS  Google Scholar 

  54. Sullivan MJ, Abbott GD, Robinson BA. Ondansetron anti-emetic therapy for chemotherapy and radiotherapy induced vomiting in children. NZ Med J 1992; 105: 369–71

    CAS  Google Scholar 

  55. Domino KB, Anderson EA, Polissar NL, et al. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. Anesth Analg 1999; 88: 1370–9

    PubMed  CAS  Google Scholar 

  56. Morton NS, Camu F, Dorman T, et al. Ondansetron reduces nausea and vomiting after paediatric adenotonsillectomy. Paediatr Anaesth 1997; 7: 37–45

    Article  PubMed  CAS  Google Scholar 

  57. Polati E, Verlato G, Finco G, et al. Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting. Anesth Analg 1997; 85: 395–9

    PubMed  CAS  Google Scholar 

  58. Splinter WM, Rhine EJ, Roberts DW, et al. Ondansetron is a better prophylactic anti-emetic than droperidol for tonsillectomy in children. J Anaesth 1995; 42: 848–51

    CAS  Google Scholar 

  59. Stene EN, Seay RE, Young LA, et al. Prospective, randomized, double-blind, placebo-controlled comparison of metoclopramide and ondansetron for prevention of posttonsillectomy or adenotonsillectomy emesis. J Clin Anesth 1996; 8: 540–4

    Article  PubMed  CAS  Google Scholar 

  60. Unlugenc H, Guler T, Gunes Y, et al. Comparative study of the anti-emetic efficacy of ondansetron, propofol and midazolam in the early postoperative period. Eur J Anaesth 2004; 21: 60–5

    CAS  Google Scholar 

  61. Dick GS, Meller ST, Pinkerton CR. Randomized comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis. Arch Dis Child 1995; 73: 243–5

    Article  PubMed  CAS  Google Scholar 

  62. Koseoglu V, Kürekçi AE, Sorici Ü, et al. Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study. Eur J Pediatr 1998; 157: 806–10

    Article  PubMed  CAS  Google Scholar 

  63. Bryson JC. Clinical safety of ondansetron. Semin Oncol 1992; 19Suppl. 15: 26–32

    PubMed  CAS  Google Scholar 

  64. Ang C, Habre W, Sims C. Tropisetron reduces vomiting after tonsillectomy in children. Br J Anaesth 1998; 80: 761–3

    Article  PubMed  CAS  Google Scholar 

  65. Cieslak GD, Watcha MF, Phillips MB, et al. The dose-response relation and cost-effectiveness of granisetron for the prophylaxis of pediatric postoperative emesis. Anesthesiology 1996; 85: 1076–85

    Article  PubMed  CAS  Google Scholar 

  66. Coopes MJ, Yanofsky R, Pritchard S, et al. Safety, tolerability, anti-emetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy. J Pediatr Hematol Oncol 1999; 21: 274–83

    Article  Google Scholar 

  67. Fujii Y, Tanaka H, Ito M. Ramosetron compared with granisetron for the prevention of vomiting following strabismus surgery in children. Br J Ophthalmol 2001; 85: 670–2

    Article  PubMed  CAS  Google Scholar 

  68. Holt R, Rask P, Coulthard KP, et al. Tropisetron plus dexamethasone is more effective than tropisetron alone for the prevention of postoperative nausea and vomiting in children undergoing tonsillectomy. Paediatr Anaesth 2000; 10: 181–8

    Article  PubMed  CAS  Google Scholar 

  69. Patel RI, Davis PJ, Orr RJ, et al. Single-dose ondansetron prevents postoperative vomiting in pediatric outpatients. Anesth Analg 1997; 85: 538–45

    PubMed  CAS  Google Scholar 

  70. Rabasseda X. Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting. Drugs Today (Barc) 2002; 38: 75–89

    Article  CAS  Google Scholar 

  71. De Negri P, Ivani G. Management of postoperative nausea and vomiting in children. Pediatr Drugs 2002; 4: 717–28

    Google Scholar 

  72. De Grandi T, Simon JE. Promethazine-induced dystonic reaction. Pediatr Emerg Care 1987; 3: 91–2

    Article  Google Scholar 

  73. Chan-Tack KM. Neuroleptic malignant syndrome due to promethazine. South Med J 1999; 92: 1017–8

    Article  PubMed  CAS  Google Scholar 

  74. Marill KA, Walsh MJ, Nelson BK. Intravenous lorazepam versus dimenhydrinate for treatment of vertigo in the emergency department: a randomized clinical trial. Am Emerg Med 2000; 36: 310–9

    Article  CAS  Google Scholar 

  75. McCall JE, Stubbs K, Saylors S, et al. The search for cost-effective prevention of postoperative nausea and vomiting in the child undergoing reconstructive burn surgery: ondansetron versus dimenhydrinate. J Burn Care Rehabil 1999; 20: 309–15

    Article  PubMed  CAS  Google Scholar 

  76. Schlager A, Mitterschiffthaler G, Pühringer F. Rectally administered dimenhydrinate reduces postoperative vomiting in children after strabismus surgery. Br J Anaesth 2000; 84: 405–6

    Article  PubMed  CAS  Google Scholar 

  77. Welters ID, Menges T, Gräf M, et al. Reduction of postoperative nausea and vomiting by dimenhydrinate suppositories for strabismus surgery in children. Anesth Analg 2000; 90: 311–4

    PubMed  CAS  Google Scholar 

  78. Leung AK, Lai PC. Use of metoclopramide for the treatment of gastroesophageal reflux in infants and children. Curr Ther Res 2004; 36: 911–5

    Google Scholar 

  79. Baines D. Postoperative nausea and vomiting in children. Paediatr Anaesth 1996; 6: 7–14

    Article  PubMed  CAS  Google Scholar 

  80. Berkovitch M, Mazzota P, Greenberg R, et al. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study. Am J Perinatol 2002; 19: 311–6

    Article  PubMed  Google Scholar 

  81. Broadman LM, Ceruzzi W, Patane PS. Metoclopramide reduces the incidence of vomiting following strabismus surgery in children. Anesthesiology 1990; 72: 245–8

    Article  PubMed  CAS  Google Scholar 

  82. Lin DM, Furst SR, Rodarie A. A double-blinded comparison of metoclopramide and droperidol for prevention of emesis following strabismus surgery. Anesthesiology 1992; 76: 357–61

    Article  PubMed  CAS  Google Scholar 

  83. Fujii Y, Saitoh Y, Tanaka H, et al. Prevention of PONV with granisetron, droperidol or metoclopramide in patients with postoperative emesis. Can J Anaesth 1998; 45: 153–6

    Article  PubMed  CAS  Google Scholar 

  84. Naguib M, El Bakry AK, Khoshim MHB, et al. Prophylactic anti-emetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo. Can J Anaesth 1996; 43: 226–31

    Article  PubMed  CAS  Google Scholar 

  85. Rose JB, Martin TM, Corddry DH, et al. Ondansetron reduces the incidence and severity of post-strabismus repair vomiting in children. Anesth Analg 1994; 79: 486–9

    Article  PubMed  CAS  Google Scholar 

  86. Batts KF, Munter DW. Metoclopramide toxicity in an infant. Pediatr Emerg Care 1998; 14: 39–41

    Article  PubMed  CAS  Google Scholar 

  87. Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Arch Intern Med 1989; 149: 2486–92

    Article  PubMed  CAS  Google Scholar 

  88. Putnam PE, Orenstein SR, Wessel HB, et al. Tardive dyskinesia associated with use of metoclopramide in a child. J Pediatr 1992; 121: 983–5

    Article  PubMed  CAS  Google Scholar 

  89. Langford JS, Sheikh S. An adolescent case of sulfhemoglobinemia associated with high-dose metoclopramide and N-acetylcysteine. Ann Emerg Med 1993; 34: 538–41

    Article  Google Scholar 

  90. Madani S, Tolia V. Gynecomastia with metoclopramide use in pediatric patients. J Clin Gastroenterol 1997; 24: 79–81

    Article  PubMed  CAS  Google Scholar 

  91. Wilson CM, Bird SG, Bocash W, et al. Methemoglobinemia following metoclopramide therapy in an infant. J Pediatr Gastroenterol Nutr 1987; 6: 640–2

    Article  PubMed  CAS  Google Scholar 

  92. Cooke RD, Comyn DJ, Ball RW. Prevention of postoperative nausea and vomiting by domperidone: a double-blind randomized study using domperidone, metoclopramide and a placebo. S Afr Med J 1979; 17: 827–9

    Google Scholar 

  93. Boghaert A, Carron D, Gallant J, et al. Postoperative vomiting treated with domperidone: a double-blind comparison with metoclopramide and a placebo. Acta Anesthesiol Belg 1980; 31: 129–37

    CAS  Google Scholar 

  94. Blanc UF, Ruest P, Milot J, et al. Anti-emetic prophylaxis with promethazine or droperidol in pediatric outpatient strabismus surgery. Can J Anaesth 1991; 38: 54–60

    Article  PubMed  CAS  Google Scholar 

  95. Fassoulaki A, Galanaki E. The anti-emetic effect of droperidol: is it dose dependent? Acta Anaesthesiol Belg 1989; 40: 179–82

    PubMed  CAS  Google Scholar 

  96. Henzi I, Sondereggar J, Tramer MR. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anesth 2000; 47: 537–55

    Article  PubMed  CAS  Google Scholar 

  97. Verheecke G, Troch E. Oral droperidol for premedication in children. Acta Anaesthesiol Belg 1985; 4: 421–6

    Google Scholar 

  98. Lischke V, Behne M, Doelken P, et al. Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg 1994; 79: 983–6

    Article  PubMed  CAS  Google Scholar 

  99. Bardfeld PA. A controlled double-blind study of trimethobenzamide, prochlorperazine, and placebo. JAMA 1996; 196: 796–8

    Article  Google Scholar 

  100. Ordog GJ, Vann PW, Owashi ND, et al. Intravenous prochlorperazine for the rapid control of vomiting in the emergency department. Ann Emerg Med 1984; 13: 253–8

    Article  PubMed  CAS  Google Scholar 

  101. Carey M, Aitken ME. Diverse effects of anti-emetic medication in children. NZ Med J 1994; 107: 452–3

    CAS  Google Scholar 

  102. Drotts DL, Vinson DR. Prochlorperazine induces akathisia in emergency patients. Ann Emerg Med 1999; 34: 469–75

    Article  PubMed  CAS  Google Scholar 

  103. Vinson DR, Drotts DZ. Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial. Ann Emerg Med 2001; 37: 125–31

    Article  PubMed  CAS  Google Scholar 

  104. Ginsburg CM, Clahsen J. Evaluation of trimethobenzamide hydrochloride (Tigan) suppositories for treatment of nausea and vomiting in children. J Pediatr 1980; 96: 767–9

    Article  PubMed  CAS  Google Scholar 

  105. Holmes C, Flaherty RJ. Trimethobenzamide hydrochloride (Tigan)-induced extra-pyramidal dysfunction in a neonate. J Pediatr 1976; 89: 669–70

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No funding was used to assist in the preparation of this review. Dr Leung has received unrestricted educational grants from Merck Frosst Canada, Fujisawa Canada, Janssen-Ortho, Bristol-Myers Squibb Canada, and Sanofi Pasteur. The authors have no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander K. C. Leung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leung, A.K.C., Robson, W.L.M. Acute Gastroenteritis in Children. Pediatr-Drugs 9, 175–184 (2007). https://doi.org/10.2165/00148581-200709030-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00148581-200709030-00006

Keywords

Navigation